4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000133
President and CEO sold 2,309 shares at $22.59 ($52,160)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2023-08-21 | Sale | −2,309 | $22.59 | $52,160 | 2,242,604 | I |
| Open-market sales · 2,309 sh · avg $22.59 · $52,160 | |||||||
Loading xslF345X05/wk-form4_1692822729.xml…